Company intelligence / Profile preview

Linjiang Hongda Pharmaceutical

Linjiang, Jilin, China

Ownership: Private
Employees: ~75
Development stage: Other

Overview

Linjiang Hongda Pharmaceutical is a Chinese pharmaceutical manufacturing company established in 2003 and based in Linjiang, Jilin Province. The company specializes in the production of traditional Chinese patent medicines (TCM) and chemical active pharmaceutical ingredients (APIs). Its product portfolio includes various formulations such as tablets, hard capsules, and granules, with notable products like Pudilan Xiaoyan tablets, Qianlie Shule capsules, and Banlangen granules. Linjiang Hongda Pharmaceutical operates a GMP-certified manufacturing facility and serves the domestic healthcare market.

Therapeutic areas: Infectious DiseasesNeurologyEndocrinologyMen's Health
Modalities: Herbal medicineBotanical extractSmall molecule
Industry: Pharma

Beyond the preview

Go deeper on Linjiang Hongda Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Linjiang Hongda Pharmaceutical.

Explore the full profile